Ferns R B, Tedder R S
J Virol Methods. 1985 Jul;11(3):231-9. doi: 10.1016/0166-0934(85)90112-0.
Monoclonal antibodies raised against HBeAg were used to develop a HBeAg and anti-HBe detection assay. Monoclones containing anti-HBe were used both for the coating of the solid phase and for the fluid phase label in a sandwich type assay. The percentage binding of 125I-labelled anti-HBe to serum HBeAg was much greater than that seen in a similar assay using only polyclonal reagents. Therefore it was possible to add a small quantity of HBeAg for neutralising any anti-HBe present in a test serum without affecting HBeAg detection. This small amount of serum HBeAg was incorporated into each test sample thus allowing the determination of the e status of a patient using only one aliquot of test serum. This single test assay could be performed either as a radioimmunoassay or as an ELISA. The sensitivity of these assays was found to be greater than the conventional polyclonal assay particularly with regard to sera containing anti-HBe.
针对HBeAg产生的单克隆抗体被用于开发一种HBeAg和抗-HBe检测方法。含有抗-HBe的单克隆抗体被用于夹心型检测中固相的包被和液相标记。125I标记的抗-HBe与血清HBeAg的结合百分比远高于仅使用多克隆试剂的类似检测。因此,可以添加少量HBeAg来中和检测血清中存在的任何抗-HBe,而不影响HBeAg的检测。将这少量的血清HBeAg加入每个测试样品中,从而仅使用一份测试血清就能确定患者的e状态。这种单一测试方法既可以作为放射免疫测定法,也可以作为酶联免疫吸附测定法进行。发现这些检测方法的灵敏度高于传统的多克隆检测方法,特别是对于含有抗-HBe的血清。